• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Basic Materials·4368.T
Share

Fuso Chemical Co.,Ltd. Stocks

¥ 4645Last Updated 24.06.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

¥ 3.01B

¥ 4645
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1952 and headquartered in Osaka, Japan, Fuso Chemical Co.,Ltd. operates globally, specializing in the manufacturing and distribution of a diverse portfolio spanning life science, electronic material, and functional chemical products. The company's life science division offers a comprehensive array of organic acids and their derivatives, including malic, citric, L-tartaric, lactic, and gluconic acids, as well as ascorbic, isoascorbic acids, and amino acid compounds. This segment also provides industrial solutions such as water-soluble rust-preventive agents and grinding/cutting fluids. For the electronics industry, Fuso Chemical produces ultra-high purity colloidal silica and high-purity organosilica sol. Additionally, its functional chemical offerings encompass various oxidation-reduction agents and benzoic acid derivatives.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 4368.T is 5352 and suggests 9.33% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.06.2026 01:21

Micron increased its profits by 1,215% and issued a forecast that exceeded market expectations. Its stock soared.

25.06.2026 00:44

JPMorgan Raised Its Forecast for the S&P 500 but Warned of the Risk of "Sudden Crashes"

25.06.2026 00:15

A South Korean supplier of Nvidia is going public on the Nasdaq. What does this mean for its competitors?

24.06.2026 23:34

Deal in the Rare Earth Metals Market: U.S. Mid-Cap Company Aims to Compete with China

24.06.2026 23:10

OpenAI and Broadcom have unveiled a new chip that will cut the cost of running AI in half

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026